Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

49.87
+0.17000.34%
Pre-market: 49.47-0.4045-0.81%08:32 EST
Volume:9.03M
Turnover:447.36M
Market Cap:19.70B
PE:-6.87
High:50.48
Open:49.16
Low:48.29
Close:49.70
52wk High:55.20
52wk Low:22.28
Shares:394.94M
Float Shares:363.29M
Volume Ratio:0.75
T/O Rate:2.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.2600
EPS(LYR):-7.2600
ROE:-28.87%
ROA:-14.51%
PB:2.28
PE(LYR):-6.87

Loading ...

Moderna price target raised to $69 from $63 at Piper Sandler

TIPRANKS
·
1 hour ago

Is Moderna (MRNA) Pricing Reflect Its mRNA Pipeline Potential After 62% Year To Date Rally

Simply Wall St.
·
6 hours ago

BREAKINGVIEWS-The Week in Breakingviews: When activists attack

Reuters
·
13 hours ago

Moderna Faces Default Risk as Ares Capital–Led Lenders Gain Power to Accelerate Debt and Seize Collateral

TIPRANKS
·
Yesterday

Weekly Winners | Omnicom Soars 21%; Moderna Surges 18%; Garmin Jumps 16%; Norwegian Cruise Gains 13%

Tiger Newspress
·
Yesterday

Bridgewater Associates' 4Q Buying and Selling -- Barron's

Dow Jones
·
Feb 21

Moderna posts FY 2025 net product sales of USD 1.82 billion (-42%)

Reuters
·
Feb 21

Mixed options sentiment in Moderna with shares down 0.31%

TIPRANKS
·
Feb 21

Moderna and Merck Advance mRNA Cancer Vaccine Trial in First-Line Lung Cancer: What Investors Should Watch

TIPRANKS
·
Feb 21

BioNTech Sues Moderna Over COVID-19 Vaccine Technology Patent

MT Newswires Live
·
Feb 20

Overnight Market Update: US Stocks Decline, Oil and Gold Advance, Trump Issues Iran Ultimatum, UK's Former Prince Andrew Released

Deep News
·
Feb 20

Stock Track | Moderna Soars 5.06% Intraday as FDA Reverses Course on Flu Vaccine Review

Stock Track
·
Feb 20

BioNTech Sues Moderna for U.S. Patent Infringement Over Covid Vaccine Mnexspike - U.S. Court Filing

THOMSON REUTERS
·
Feb 20

Moderna to Present at TD Cowen and Barclays Global Healthcare Conferences

Reuters
·
Feb 19

Markets Are in the AI Doldrums. Why Trump's Iran Posturing Could Change That. -- Barrons.com

Dow Jones
·
Feb 19

Sweden's Nanexa Q4 revenue jumps

Reuters
·
Feb 19

PRESS DIGEST -Wall Street Journal - February 19

Reuters
·
Feb 19

Dow Jones Top Company Headlines at 5 PM ET: FDA Reverses Course and Will Now Review Moderna's Flu Shot | Nvidia ...

Dow Jones
·
Feb 19

Moderna Inc. Stock Rallies 6.1%, Outperforms Peers

Dow Jones
·
Feb 19

Moderna Loses Two Defenses in Patent Infringement Case Against Arbutus Biopharma

MT Newswires Live
·
Feb 19